3.33Open3.33Pre Close0 Volume25 Open Interest15.00Strike Price0.00Turnover113.44%IV6.02%PremiumDec 20, 2024Expiry Date2.29Intrinsic Value100Multiplier5DDays to Expiry1.04Extrinsic Value100Contract SizeAmericanOptions Type0.8743Delta0.0906Gamma7.06Leverage Ratio-0.0486Theta0.0017Rho6.17Eff Leverage0.0042Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet